N@N

TomoTherapy Partners With Monmouth Medical Center to Train Radiation Oncologists in Use of Advanced Radiation Therapy Technolog

^{Published on 2009-12-08 12:46:48 - Market Wire}
 

MADISON, WI--(Marketwire - December 8, 2009) - [ TomoTherapy Incorporated ] (NASDAQ: [ TOMO ]) announced today that it has expanded its [ Institute of Learning ] curriculum to include a course for radiation oncologists. The course, which is being offered in partnership with [ Monmouth Medical Center ] of Long Branch, N.J., is designed to introduce physicians to the fundamentals of the TomoTherapy® platform and its use in a clinical setting.

The radiation oncologist course on TomoTherapy technology is collaboratively taught by physicians Mitchell Weiss, M.D., and Sang Sim, M.D., along with physicist Jack Yang, Ph.D., all of whom are members of Monmouth's radiation oncology team and have been using TomoTherapy technology since 2008.

"Hosting this type of program allows us to share our TomoTherapy experience with others, so they can smoothly transition to the TomoTherapy platform," said Dr. Weiss. "At the same time it allows for collaboration and for the opportunity to learn from each other."

The new training course was piloted in November 2009 at Monmouth Medical Center. Four physicians from TomoTherapy treatment centers around the world attended the three-day course focused on peer-to-peer learning. According to James Coster, M.D., a radiation oncologist with [ US Oncology, Inc. ], affiliate [ Kansas City Cancer Center ], the new program addresses an important need. "From expanding what I consider an appropriate range of applications to improving treatment planning strategies, the M.D. training course was extremely valuable to me as a new user," said Dr. Coster. "Instruction like this should accelerate one's ascent up the learning curve for this unique technology."

In 2010, there will be four TomoTherapy physician training courses held throughout the year. TomoTherapy also is considering adding advanced training for radiation oncologists.

"The TomoTherapy platform is the next-generation in radiation therapy -- a solution capable of providing more precise treatments for a wider range of cancer patients," said Kelly Conway, director of organizational development and global learning at TomoTherapy. "It is important for our customers to have an array of educational opportunities that help them optimize use of TomoTherapy technology. Adding courses for physicians is a step forward for our industry-leading training program."

About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy's suite of solutions include its flagship Hi·Art® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit [ TomoTherapy.com ].

©2009 TomoTherapy Incorporated. All rights reserved. The following marks as used herein in italicized or stylized text are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries: TomoTherapy, Tomo, TomoDirect, TomoHelical, TomoHD, TomoMobile, TQA, Hi·Art, and the TomoTherapy logo.